Society
of Cardiovascular Anesthesiologists
CME Requirements
Slide
#1: Title of lecture
Slide
#2: Lecture objective
Slide
#3: Disclosure (even if you have nothing to disclose)
The
Accreditation Council for Continuing Medical Education (ACCME) accredits SCA.
As such, we have made the choice to meet the ACCME’s
expectations for our practice of continuing medical education. Our
accreditation is important to us. We look forward to working together to
provide CME at the highest standard.
SCA
has implemented a process wherein everyone who is in a position to control the
content of an educational activity has disclosed to us all relevant financial
relationships with any commercial interest. In addition, should it be
determined that a conflict of interest exists as a result of a financial
relationship you may have, this will need to be resolved prior to the activity.
If you refuse to disclose relevant financial relationships, you will be disqualified
from being a part of the CME activity.
The
Commercial Support Standards also require that your presentation is free of
commercial bias and that any information regarding commercial products/services
be based on scientific methods generally accepted by the medical community.
When discussing therapeutic options, it is our preference that you use only
generic names. If it is necessary to use a trade name, then those of several
companies be used. Further, should your presentation
include discussion of any unlabeled/investigational use of a commercial
product, you are required to disclose this to the participants. Should you
determine that you cannot comply with these requirements or any of the
provisions, please contact the SCA Administrative Office as soon as possible.
A) Generic and Trade Names
– Presentations must give a balanced view of therapeutic options.
Presenter’s use of general names will contribute to this impartiality. If
trade names are used, those of several companies should be used rather than
only that of a single supporting company.
B) Unlabeled Uses of Products
– When an unlabeled use of a commercial product, or an investigational
use not yet approved for any purpose is discussed during an educational
activity, the presenter is required to disclose that the product is not labeled
for the use under discussion or that the product is still investigational.
It
is the Society’s policy to conduct post-activity evaluations. These
evaluations ask participants to indicate the appropriateness of the presentations
to their specific practices, if the presentations satisfied the stated
objectives, if they were satisfied with the faculty presentations and if there
was any evidence of commercial bias. The results of these evaluations are used
to plan future CME activities and are shared with the faculty.
Once
again thank you for your willingness to participate in this event. We have
worked hard to develop a program which will meet the expressed needs of our
expected participants, who we anticipate will come from the